2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.
2N Pharma CEO, Preben Bruun-Nyzell, and CSO, Dr John Nieland, will participate in the 3rd ALS Drug Development Summit in Boston, 21-23 May 2024. This is a fantastic opportunity to engage with the world’s leading ALS drug development companies.